News from PROTEIN SCIENCES CORPORATION A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 22, 2017, 10:07 ET Protein Sciences and Partnership for Influenza Vaccine Introduction (PIVI) Team Up to Combat the Flu in Mongolia

Protein Sciences Corporation, a leading vaccine development company and maker of Flublok® Influenza Vaccine, announced today that they donated...


Jan 12, 2017, 10:17 ET Protein Sciences Zika Vaccine Shows Good Results in Preclinical Testing

Protein Sciences Corporation, a leading vaccine development company and maker of Flublok Influenza Vaccine®, announced today that its lead protein...


Oct 26, 2016, 11:07 ET Flublok® Influenza Vaccine Now Available in Mexico

Mexico welcomed the availability of Flublok last Thursday with the official launch of Flublok influenza vaccine in Mexico City. Mexican regulatory...


Oct 20, 2016, 12:07 ET Protein Sciences Launches Social Media Campaign for Flublok® Influenza Vaccine to Raise Money for Health-based Charities

Protein Sciences Corporation proudly announced the launch of a new social media campaign - #ShowMeTheVial - featuring Flublok® influenza vaccine...


Oct 11, 2016, 13:15 ET FDA Approves Flublok® Quadrivalent Influenza Vaccine

Protein Sciences Corporation announced today that the FDA has approved its quadrivalent formulation of Flublok® influenza vaccine. Flublok...


Sep 22, 2016, 10:07 ET Protein Sciences and Avanzcare Announce Licensing of Influenza Vaccines for the MENA Region

Protein Sciences Corporation (headquarters: Meriden, CT, USA) and Avanzcare, the medical arm of Al Sawari Holding (headquarters: Doha, Qatar)...


Sep 07, 2016, 10:07 ET U.S. Biomedical Advanced Research and Development Authority (BARDA) Awards Protein Sciences Multi-Million Dollar Contract for Pandemic Preparedness

Protein Sciences Corporation announced today that the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S....


Aug 10, 2016, 10:47 ET First Doses of Flublok® Influenza Vaccine of 2016/17 Have Shipped

Protein Sciences Corporation announced that the FDA has approved and released the first lots of Flublok® influenza vaccine for distribution...


Jul 12, 2016, 10:07 ET 2016/17 Formulation of Flublok® Influenza Vaccine Receives FDA Approval

Protein Sciences Corporation announced that FDA has approved the 2016/17 formulation of Flublok® influenza vaccine.   Unlike...


Jun 30, 2016, 10:36 ET Flublok® Influenza Vaccine is a great alternative for FluMist for adults 18 and older

 On Wednesday, the CDC's Advisory Committee on Immunization Practices (ACIP) recommended against the use of live attenuated influenza vaccine...


Jun 29, 2016, 10:07 ET UMN Pharma Joins Protein Sciences' International Zika Vaccine Consortium

USA and Japan -- Protein Sciences Corporation, manufacturer of Flublok® influenza vaccine, and UMN Pharma Inc. (Akita, Akita prefecture,...


Jun 28, 2016, 10:07 ET Protein Sciences Announces Exclusive License to uniQure of Cell Line and Technology for Production of Human Gene Therapies

Protein Sciences Corporation, makers of Flublok® influenza vaccine, announced today that they have entered into an agreement with uniQure NV,...


Jun 23, 2016, 11:15 ET FDA Approved Longer Shelf Life for the Game Changer, Flublok® Influenza Vaccine

Protein Sciences Corporation announced today that FDA has extended the shelf life for Flublok, its game changing seasonal influenza vaccine, to 9...


Feb 12, 2016, 09:29 ET Protein Sciences and UNIGEN Reach Agreement to Source Flublok® Influenza Vaccine from Japan

 Protein Sciences Corporation (Meriden, CT and Pearl River, NY) and UMN Pharma Inc. (Akita, Akita prefecture, Japan) announced today that...


Nov 18, 2015, 10:52 ET Flublok® Influenza Vaccine Approved in Mexico

Protein Sciences Corporation, manufacturer of Flublok®, is pleased to announce that Laboratorios Liomont, S.A. de C.V. (Liomont), a leading...


Nov 12, 2015, 10:07 ET Protein Sciences Awarded a Small Business Innovation Research Grant for the Development of a Novel Adenovirus Vaccine

 Protein Sciences Corporation, makers of Flublok® Influenza Vaccine, announced today that they have been awarded a Phase I Small...


Oct 29, 2015, 11:55 ET Protein Sciences President and CEO Manon Cox Elected as 2015 Fellow of the International Society for Vaccines

Protein Sciences Corporation, the makers of Flublok®Influenza Vaccine, announced today that Dr. Manon Cox, President and CEO, was elected as a...


May 13, 2015, 12:24 ET Protein Sciences New York Facility Receives FDA Licensure to Manufacture Flublok®

Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration (FDA) licensed its Pearl River, NY manufacturing...


Jan 29, 2015, 10:06 ET Clinical Efficacy Study of Flublok® Quadrivalent Compares Flublok to a Traditional Egg-based Flu Vaccine

 Protein Sciences Corporation announced today that results from a double-blinded comparative efficacy study of Flublok Quadrivalent in adults...


Dec 22, 2014, 10:01 ET Protein Sciences, UMN Pharma and IHI Corporation Enter into an Agreement to Evaluate Sourcing Flublok® from Japan

Protein Sciences Corporation (Meriden, CT and Pearl River, NY), UMN Pharma Inc. (Akita, Akita prefecture, Japan) and IHI Corporation (Koto-ku,...


Oct 29, 2014, 16:44 ET Flublok® Influenza Vaccine Now Approved for Adults Ages 18 and Older

Protein Sciences Corporation announced today that the U.S. FDA has approved Flublok influenza vaccine for all adults aged 18 years and older,...


Sep 29, 2014, 10:07 ET Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season

 Protein Sciences Corporation, manufacturer of the revolutionary Flublok influenza vaccine, announced today that doses of the vaccine have been...


Sep 16, 2014, 07:07 ET Protein Sciences and Diamyd Medical Deepen Commitment to Develop New Treatment for Diabetes

 Protein Sciences Corporation and Diamyd Medical AB announced today that Protein Sciences has broadened its commitment to diabetes and become a...


Aug 19, 2014, 10:07 ET Flublok® Influenza Vaccine Will Be Available At Over 230 Passport Health Locations Nationwide

 Protein Sciences Corporation and Passport Health announced today that Flublok® influenza vaccine will be available this fall at all 230+...


Aug 12, 2014, 10:07 ET Protein Sciences and Liomont Announce Licensing of Proprietary Influenza Vaccines for the Mexico Market

 Protein Sciences Corporation and Laboratorios Liomont, S.A. de C.V. (Liomont), a leading Mexican pharmaceutical company, announced today that...